WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Chowdary et al. SJIF Impact Factor 6.647 Volume 6, Issue 4, 1093-1099 Research Article ISSN 2278 4357 IMPACT OF PATIENT COUNSELING BY CLINICAL PHARMACIST ON QUALITY OF LIFE IN CANCER PATIENTS V. S. L. Deepthi, K. J. V. Haneesh and *K. P. R. Chowdary Department of Pharmacy Practice Vikas Institute of Pharmaceutical Sciences, Nidigatla Road, Rajahmundry- 533102. Article Received on 26 Jan. 2017, Revised on 15 Feb. 2017, Accepted on 08 March 2017 DOI: 10.20959/wjpps20174-8817 *Corresponding Author Prof. K.P.R. Chowdary Department of Pharmacy Practice Vikas Institute of Pharmaceutical Sciences, Nidigatla Road, Rajahmundry- 533102. ABSTRACT Cancer is the leading cause of mortality among the world population. It is a distressing situation for everyone those who have known to be diagnosed with cancer. Main aim of the cancer treatment is to reduce the symptoms, enhance their survival and quality of life (Qol). Quality of life is an important health outcome indicator most relevant incase of cancer patient. As per WHO, Quality of life is defined as individuals perception of their position in life in the context of culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. Patient counseling is one of the most powerful predictors of patient compliance and inspires the patient to see pharmacist as a truly interested healthcare professionals. Patient education and medication counseling are an integral part of health process that will improve quality of life and patient outcome. Patient counseling mainly aims to enhance patient understanding about their illness and treatment focusing on medications and its use. In order to attain full potential, the patients need to follow some changes in their lifestyle, nutritional aspects and in physical activities especially incase of cancer patients. Management of cancer counseling by clinical pharmacist and its impact on the quality of life of cancer patients are discussed in this presentation. KEYWORDS: Patient Counseling, Clinical Pharmacist, Quality of Life, Cancer patients. INTRODUCTION Cancer is the leading cause of mortality among the world population. It is a distressing situation for everyone those who have known to be diagnosed with cancer. Main aim of the www.wjpps.com Vol 6, Issue 4, 2017. 1093
cancer treatment is to reduce the symptoms, enhance their survival and quality of life (Qol). Quality of life is an important health outcome indicator most relevant incase of cancer patient. As per WHO, Quality of life is defined as individuals perception of their position in life in the context of culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. [1] Patient counseling is one of the most powerful predictors of patient compliance and inspires the patient to see pharmacist as a truly interested healthcare professionals. [2] It is important to provide palliative treatment and assist them in improving their Quality of Life (QoL). Although people with cancer are now able to live longer due to medical advancements they often experience many physical changes which can negatively influence on their psychological status and interfere with the quality of their life. So measurement of quality of life and patient education are essential in cancer patients. Based on that it is a study that mainly focused on to enhance Quality of life in cancer patients through effective patient counselling. In the current study an attempt has been made to assess if there is any improvement in the quality of life and to provide knowledge and awareness regarding nature of disease, the importance and expected outcomes regarding various treatment aspects, adherence to medication, life style, exercise, management of side effects and dietary restrictions. METHODOLOGY It was a six month study carried out with the consent of patients who visiting the oncology department for the treatment of cancer. The sample size required for the study was calculated using Paired t-test. As per the test minimum sample size required was 117. This study was approved by the Central Ethics Committee. Outpatients of either gender with 18 years of age and above diagnosed with any type of cancer, visiting outpatient department of oncology unit were included in the study. Patients those are not willing to participate, mentally challenged and Patients with difficulty in speaking were excluded from the study. A validated European organization for research and treatment of cancer questionnaire was used in the study for the measurement of quality of life. The process of randomization was done by chit method and the groups were randomly assigned into interventional and usual care groups. The intervention group was given patient counseling and leaflet education along with the doctor's treatment. Usual care group received the usual care provided by the doctors, nurses and technicians and the patient counseling education and leaflets were provided to them at the end of the study. The quality of life for the both groups was evaluated at baseline and at sixth www.wjpps.com Vol 6, Issue 4, 2017. 1094
month. The Collected data was analysed by using descriptive statistics (mean ± S.D) and analytical statistics. Data were analysed by using SPSS software version 16. RESULTS AND DISCUSSION A total of 141 patients were included in the study and randomised into intervention (70) and usual care group (71). 5 patients from usual care and 6 patients from intervention group were dropped out. Finally 130 patients (65 from each group) completed the study. Distribution of demographic, baseline and clinical characteristics among study population. Among study population Females 68(52.3%) were found to be more followed by males 62 (47.7%). The prevalence of disease found to be more common in 50-59 age groups. Chi-square and fishers exact test shows no difference in baseline characteristics between intervention and usual care (P>0.05). The results were given in the following tables [table1 & table 2]. Table 1: Distribution of cancer based on gender and age USUAL Chi p INTERVENTION TOTAL Demographics CARE square value N % N % N % Gender Male 32 49.2 30 46.2 62 47.7 0.424 0.515 Female 33 50.8 35 53.8 68 52.3 Age 20-29 1 1.5 1 1.5 2 1.5 28.737** 0.358 30-39 6 9.2 5 7.7 11 8.5 40-49 14 21.5 15 23.1 29 22.3 50-59 21 32.3 25 38.5 46 35.4 60-60 20 30.8 14 21.5 34 26.2 70 3 4.6 5 7.7 8 6.2 N-Frequency, **Fishers exact test, Table 2: Distribution of Baseline characteristics among the study population Intervention Usual care Total Chi square P value Charecteristics N % N % N % Diet Vegetarian 4 6.2 2 3.1 6 4.6 2** 0.608 Mixed 61 93.8 63 96.9 124 95.4 Marital Single 2 3.1 2 3.1 4 3.1 2** 0.719 Married 61 96.9 63 96.9 126 96.9 Education Illiterate 16 24.6 21 32.3 37 28.5 8.06** 0.557 Primary 30 46.2 31 47.7 61 46.9 High school 17 26.2 11 16.9 28 21.5 Degree 2 3.1 2 3.1 4 3.1 Employment Employed 10 15.4 7 10.6 17 13.2 1.861** 0.377 www.wjpps.com Vol 6, Issue 4, 2017. 1095
Unemployed 53 81.5 58 89.2 111 85.4 Retired 2 3.1 0 0 2 1.5 Area living Rural 45 69.2 56 86.2 101 77.7 0.397 0.528 Urban 20 30.8 9 13.8 29 22.3 Family history No 53 81.5 51 78.5 104 80 15.615** 0.646 1 st degree 6 9.2 6 9.2 12 9.2 2 nd degree 6 10.9 8 12.3 14 10.8 Annual income Low 36 55.3 41 63.1 77 59.23 6.46** 0.7 Medium 24 36.9 23 35.4 47 36.2 High 5 7.7 1 1.5 6 4.6 Health insurance Yes 41 63.1 50 76.9 91 70 2** 0.313 No 24 36.9 15 23.1 39 30 Annual check up Yes 9 13.8 1 1.5 10 7.7 0.163 0.686 56 86.2 64 98.5 120 92.3 N-Frequency, **Fishers. ASSESSMENT OF LIFESTYLE AMONG PATIENTS WITH CANCER BEFORE AND AFTER DIAGNOSIS Study assessed the life style pattern of patients before diagnosis and after diagnosis through closed ended questions. Information's of cancer patients lifestyle before diagnosis and after diagnosis was assessed separately in the intervention and usual care group. Main aim of this evaluation is to understand their past, current lifestyle, mental status and to give a better counseling individually. According to epidemiological studies 80-90% of all cancers are due to environmental factor among which lifestyle is more prominent and preventable. [6] The major risk factors are chewing of betel nut, smoking/ tobacco, lack of exercise, low vegetable and fruit consumption, more red meat consumption e.t.c. In the current study around 46.2% and 1.5% were on smoking/betel nut habits and, around 30% and 3.1% were on alcohol consumption before their cancer diagnosis and after their diagnosis respectively. Before cancer diagnosis only 3% were on Exercise and that increased to 39.2% after diagnosis and only 33.1% was on more vegetable and fruit consumption before and that increased only to 58.5% after diagnosis. Also found that 56.9% were on meat consumption before and 41.5% were on still meat consumption after diagnosis. Spirituality of patients were increased (93.2%) after diagnosis, sexual life was unhappy for 53.8% patients after their diagnosis and family life was unhappy for 23.8% after diagnosis. These results indicating lack of awareness about lifestyle and patient mental status with fear and anxiety and also suggesting that need of counseling. www.wjpps.com Vol 6, Issue 4, 2017. 1096
The present study also assessed the relation of lifestyle with occurrence of cancer in both group(intervention and usual care). The relation of lifestyle with occurrence of cancer was evaluated separately in the intervention and usual care group. The findings suggest that smoking/betel nut have relation with head and neck, gastrointestinal and respiratory cancer at 5% level of significance(p<0.05) also found that alcohol consumption existing a relation with head and neck, gastrointestinal and respiratory cancer at 5% level of significance(p<0.05). These habits is found to be a contributing factor for cancer incidence. Social habits have influence on disease state. [6,7,8] MEASUREMENT OF QUALITY OF LIFE IN CANCER PATIENTS - Result of paired t test From the table 3 it was noticed that a significant improvement in quality of life can be seen in intervention group patients. Along with that increment in functional scales such as emotional, physical, Role, Social and cognitive can also found. A higher increment in emotional functioning scores can be seen in intervention group compared to usual care group. From the table it is clear that the p values for quality of life and functional scales of Intervention group is <0.05. It indicates there is a difference (Mean base line < mean follow up) in scores before and after counseling. But such a significant difference cannot be seen in the usual care group. Paired "t" test reveals that pharmacists counseling is effective in improving Quality of life among cancer patients at the 5% level of significance. Whereas within usual care group at baseline and final follow up there is a difference in social functioning, pain, nausea and vomiting, along with quality of life also. That is expected to be because of the better treatment provided by the hospital. Some study shows after radiotherapy and chemotherapy can see improvement in quality of life [10,16,18] and in symptom scale especially in pain, insomnia, appetite loss, constipation. In the current study the effectiveness of counselling between intervention and usual care group were evaluated by Independent sample t test (table 4) where compared the difference between usual care and intervention group (baseline- Follow up). It is found that there is a difference in scale scores between intervention and usual care group (pre-post)for Quality of life, emotional functioning, appetite loss, constipation, insomnia, fatigue, pain and financial difficulties(p<0.05). Indicating there is a difference in mean scores of all these scales at 5% Level of significance, which means pharmacist counselling have a significant impact on improving the quality of life in the intervention group as compared to group that was not provided with an intervention. www.wjpps.com Vol 6, Issue 4, 2017. 1097
Table 3. Comparison of quality of life and functional scales within the groups by using paired t test Global Health Status Quality Of Life Physical Role Emotional Cognitive Social function Baseline Follow Up Paired T Test Intervention Usual Care Intervention Usual Care Intervention Usual Care T P T P Mean SD Mean SD Mean SD Mean SD Value Value Value Value 51.15 13.81 50.71 11.01 67.30 7.97 56.02 7.73 8.802 <0.001 3.986 <0.001 72.61 16.58 71.07 20.22 83.39 11.85 70.15 16.42 5.92 <0.001 0.34 0.74 71.28 19.66 71.54 22.96 83.08 14.28 72.05 17.21 4.62 <0.001 0.16 0.87 63.33 17.97 64.99 21.05 91.80 9.60 62.95 19.32 13.46 <0.001 0.76 0.45 83.33 21.04 85.64 19.74 94.62 11.07 87.18 15.24 4.45 <0.001 0.74 0.47 59.74 22.42 63.85 24.40 72.05 18.42 55.64 19.61 3.71 <0.001 2.80 0.01* Result of Independent sample t test: Table 4: Comparison of Quality of life and functional scale between groups (Baselinefinal follow up) Global Health Intervention Usual Care Status Mean SD Mean SD T Value P Value Quality Of Life 17.69 12.89 9.102 8.43 4.499 <0.001* al Scale Physical 12.82 12.87 15.69 15.20 1.16 0.25 Role 14.87 18.43 17.95 18.71 0.95 0.35 Emotional 28.462 17.045 15.641 15.06 4.544 <0.001* Cognitive 12.82 19.491 9.23 14.139 1.202 0.232 Social 21.538 19.922 16.923 18.279 1.376 0.171 *(p<0.05) significant at the 5% level of significance. CONCLUSION 1. The study concludes that the pharmaceutical care services provided by the clinical pharmacist can establish a better patient pharmacist relationship and thereby results improved quality of life in cancer patients. 2. Most of the patients are diagnosed at advanced stages, the health authorities can take initiations to carry out cancer awareness programes and high risk population more frequently, especially in rural areas. Thus, incidences can be reduced. www.wjpps.com Vol 6, Issue 4, 2017. 1098
3. In community settings pharmacist can also extend their services in cancer awareness programmes in high risk categories. REFERENCES 1. N.Udupa, Anantha Naik Nagappa. Fundamentals of pharmaceutical care. first edition, 2. Bangalore: prism books; 2014. 3. World health Organization Quality of life. Measuring Quality of life. Available on 4. http://www.who.int/mental_health/media/68. 5. Damodar G,Smitha T,yedukondala Rao a, A Descriptive epidemiological study of cancers at a south Indian tertiary care hospital. Research J Pharma, Biological Chemical Sci 2011; 2(4): 907-912. 6. Wahnefried WD, Jones LW, promoting a Healthy Lifestyle among Cancer Survivors. Hematol Oncol Clin North Am. 2008 April; 22(2): 319 342. 7. G Damodar, S Gopinath, S vijayakumar, A yedukondala Rao. Reasons for Low Quality of Life in South Indian Cancer Patient Population: A Prospective Observational Study. Indian J Pharm Sci. Jan-Feb 2014; 76(1): 2 9. 8. Khandelwal S, KL bairy, MS vidyasagar, gonsalves J, bharti chogtu. quality of life in cancer patients on chemotherapy. world journal of pharmacy and pharmaceutical sciences. April 2015; 4(05): 918-928. 9. Olschewski M, Schulgen G, Schumacher M, Altman DG.Quality of life assessment in clinical cancer research. British journal of cancer. March 1994; 70: 1-5. 10. Heydarnejad MS, Dehkordi A, Dehkordi K. Factors affecting quality of life in cancer patients undergoing chemotherapy. African Health Sciences. June 2011; 11(2): 266-270. www.wjpps.com Vol 6, Issue 4, 2017. 1099